Follow the people · Insider

SG

Sarah Gheuens

Insider · Chief Medical Officer · AGIO

Sarah Gheuens files insider transactions with the SEC as a chief medical officer of Agios Pharmaceuticals (AGIO). We hold 5 disclosed purchases and sales filed since 7 December 2021, 2 of them in the last 90 days.

  • Files forAGIO
  • Disclosed buys and sells5 in all, 2 in the last 90 days
  • Last disclosure6 August 2026

Positions held

2 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 2 December 20214 August 2026Chief Medical Officer · Agios Pharmaceuticals (AGIO)118 Form 4 lines · source: SEC Form 4
  • Filed 21 September 20231 July 2026Director · Viridian Therapeutics, Inc.\DE (VRDN)4 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.